These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38915908)

  • 1. Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
    Schroth M; Deans J; Arya K; Castro D; De Vivo DC; Gibbons MA; Ionita C; Kuntz NL; Lakhotia A; Neil Knierbein E; Scoto M; Sejersen T; Servais L; Tian C; Waldrop MA; Vázquez-Costa JF
    Neurol Clin Pract; 2024 Aug; 14(4):e200310. PubMed ID: 38915908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.
    Schroth MK; Deans J; Bharucha Goebel DX; Burnette WB; Darras BT; Elsheikh BH; Felker MV; Klein A; Krueger J; Proud CM; Veerapandiyan A; Graham RJ
    Neurol Clin Pract; 2025 Feb; 15(1):e200374. PubMed ID: 39399564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
    Hoy SM
    CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation.
    Krosschell KJ; Dunaway Young S; Peterson I; Curry M; Mazzella A; Jarecki J; Cruz R
    Phys Ther; 2022 Oct; 102(10):. PubMed ID: 35904447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States.
    Zaidman CM; Crockett CD; Wedge E; Tabatabai G; Goedeker N
    Int J Neonatal Screen; 2024 Aug; 10(3):. PubMed ID: 39189230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report.
    Hashimoto K; Yokokawa M; Yamashita D; Yuge K; Otsubo Y
    Cureus; 2023 Jul; 15(7):e42382. PubMed ID: 37621829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Pilot Study Results of Newborn Screening for Spinal Muscular Atrophy in the Republic of Croatia.
    Šimić D; Šarić A; Škaričić A; Lehman I; Bunoza B; Rako I; Fumić K
    Int J Neonatal Screen; 2024 Jul; 10(3):. PubMed ID: 39051406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus).
    Pitarch Castellano I; Cabrera-Serrano M; Calvo Medina R; Cattinari MG; Espinosa García S; Fernández-Ramos JA; García Campos O; Gómez-Andrés D; Grimalt Calatayud MA; Gutiérrez Martínez AJ; Ibáñez Albert E; Kapetanovic García S; Madruga-Garrido M; Martínez-Moreno M; Medina Cantillo J; Melián Suárez AI; Moreno Escribano A; Munell F; Nascimento Osorio A; Pascual-Pascual SI; Povedano M; Santana Casiano IM; Vázquez-Costa JF
    Neurologia (Engl Ed); 2022 Apr; 37(3):216-228. PubMed ID: 35241415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
    Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C
    Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment for spinal muscular atrophy type I.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD006281. PubMed ID: 31825542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation.
    Mikhalchuk K; Shchagina O; Chukhrova A; Zabnenkova V; Chausova P; Ryadninskaya N; Vlodavets D; Kutsev SI; Polyakov A
    Int J Neonatal Screen; 2023 May; 9(2):. PubMed ID: 37218894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.